Updated:
LDS Biotech
LDS Biotech operates as a single-family office based in Jerusalem, Israel.
LDS Biotech
LDS Biotech operates as a single-family office based in Jerusalem, Israel. The firm's founding year and wealth origin are not publicly disclosed, per available records. Its investment activity centers on early-stage biotech and digital health companies, with a stated focus on Israeli and Middle Eastern markets. The firm targets startup-stage investments across advanced materials, biotech, digital health, and cannabis/psychedelics. It invests directly into operating companies rather than through third-party funds. A known portfolio company is not publicly named, but sector tags align with the firm's published focus areas on communications and public filings. LDS Biotech's team size and additional offices are not publicly available. The firm appears to operate as a standalone entity, without disclosed philanthropic or operating-company structures. No verifiable recent operational events from the last 24 months have been identified in public sources. A structural differentiator is the firm's explicit focus on Israel and the Middle East for biotech and digital health deals, aligning capital with regional scientific research clusters. This geographic concentration, alongside its direct-investment operating model, distinguishes it from more geographically diversified family offices in life sciences.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Middle East
Country
Israel
City
Jerusalem
Corporate office
Jerusalem, Israel
Sector focus
Frequently asked questions
Who runs investment decisions at LDS Biotech?
LDS Biotech does not publicly name its principals or investment committee members. The firm's website and public filings do not disclose specific individuals, per available records.
How does LDS Biotech source proprietary deal flow?
The firm sources deals through its network in Israeli and Middle Eastern life-science ecosystems. It focuses on early-stage startups and likely relies on direct relationships with academic institutions, research centers, and local venture networks.
Is LDS Biotech structured as a single family office or does it operate more like a venture firm?
Public records indicate LDS Biotech is a family office, not a traditional venture firm. It does not actively market to external LPs or sponsors funds, and likely manages capital for a single family.
What investment stages does LDS Biotech typically target?
The firm targets startup-stage investments, per its investment-type focus on startups. This suggests seed-stage and early-growth companies in its core sectors.
Which sectors does LDS Biotech explicitly avoid?
LDS Biotech's public profile does not list sectors it avoids. Its stated focus areas include digital health, cannabis/psychedelics, advanced materials, and biotech, implying concentration in life sciences and adjacent technologies.
Does LDS Biotech participate in fund commitments or only direct deals?
Available information suggests LDS Biotech invests directly into startups rather than making fund commitments. Its investment-type classification as 'Startups' supports a direct-investment approach.
Where does the underlying wealth come from?
The wealth origin for LDS Biotech is not publicly disclosed. The firm's name and biotech focus may suggest a connection to the LDS (likely Latter-day Saints) community, but no direct confirmation exists in public sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: